Functional Analysis of Mutations within the Kinase Activation Segment of B-Raf in Human Colorectal Tumors

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8132-8137

  Ikenoue, Tsuneo ^a,b   Hikiba, Yohko ^a   Kanai, Fumihiko ^b   Tanaka, Yasuo ^b   Imamura, Jun ^b   Imamura, Takaaki ^b   Ohta, Miki ^b   Ijichi, Hideaki ^b   Tateishi, Keisuke ^b   Kawakami, Takayuki ^b   Aragaki, Jun ^a   Matsumura, Masayuki ^a,b   Kawabe, Takao ^b   Omata, Masao ^b  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; B RAF GENE; CARCINOGENESIS; CELL STRAIN 3T3; CELL TRANSFORMATION; COLORECTAL TUMOR; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MAP KINASE KINASE KINASE 1; MAP KINASE KINASE KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; NIH 3T3 CELLS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TYROSINE 3-MONOOXYGENASE;

EID: 10744232660     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Morrison, D. K., and Cutler, R. E. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol., 9: 174-179, 1997.
2. Kolch, W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ ERK pathway by protein interactions. Biochem. J., 351: 289-305, 2000.
3. Avruch, J., Khokhlatchev, A., Kyriakis, J. M., Luo, Z., Tzivion, G., Vavvas, D., and Zhang, X. F. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog. Horm. Res., 56: 127-155, 2001.
4. Peyssonnaux, C., and Eychene, A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell, 93: 53-62, 2001.
5. Karin, M., and Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol., 18: 621-663, 2000.
6. Israel, A. The IKK complex: an integrator of all signals that activate NF-κB? Trends Cell Biol., 10: 129-133, 2000.
7. Ghosh, S., and Karin, M. Missing pieces in the NF-κB puzzle. Cell, 109: 81-96, 2002.
8. Baumann, B., Weber, C. K., Troppmair, J., Whiteside, S., Israel, A., Rapp, U. R., and Wirth, T. Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc. Natl. Acad. Sci. USA, 97: 4615-4620, 2000.
9. McCarthy, S. A., Samuels, M. L., Pritchard, C. A., Abraham, J. A., and McMahon, M. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes. Genes Dev., 9: 1953-1964, 1995.
10. Kerkhoff, E., and Rapp, U. R. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol., 17: 2576-2586, 1997.
11. Vale, T., Ngo, T. T., White, M. A., and Lipsky, P. E. Raf-induced transformation requires an interleukin 1 autocrine loop. Cancer Res., 61: 602-607, 2001.
12. Zhang, B. H., and Guan, K. L. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J., 19: 5429-5439, 2000.
13. Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B. A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G. J., Bigner, D. D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J. W., Leung, S. Y., Yuen, S. T., Weber, B. L., Seigler, H. F., Darrow, T. L., Paterson, H., Marais, R., Marshall, C. J., Wooster, R., Stratton, M. R., and Futreal, P. A. Mutations of the BRAF gene in human cancer. Nature (Lond.), 417: 949-954, 2002.
14. Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., and Velculescu, V. E. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (Lond.), 418: 934, 2002.
15. Yuen, S. T., Davies, H., Chan, T. L., Ho, J. W., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Tsui, W. W., Chan, A. S., Futreal, P. A., Stratton, M. R., Wooster, R., and Leung, S. Y. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res., 62: 6451-6455, 2002.
16. Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., Salem, G., Pohida, T., Heenan, P., Duray, P., Kallioniemi, O., Hayward, N. K., Trent, J. M., and Meltzer, P. S. High frequency of BRAF mutations in nevi. Nat. Genet., 33: 19-20, 2003.
17. Brosc, M. S., Volpe, P., Feldman, M., Kumar, M., Rishi, I., Gerrero, R., Einhorn, E., Herlyn, M., Minna, J., Nicholson, A., Roth, J. A., Albelda, S. M., Davies, H., Cox, C., Brignell, G., Stephens, P., Futreal, P. A., Wooster, R., Stratton, M. R., and Weber, B. L. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res., 62: 6997-7000, 2002.
18. Naoki, K., Chen, T. H., Richards, W. G., Sugarbaker, D. J., and Meyerson, M. Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res., 62: 7001-7003, 2002.
19. Cohen, Y., Xing, M., Mambo, E., Guo, Z., Wu, G., Trink, B., Beller, U., Westra, W. H., Ladenson, P. W., and Sidransky, D. BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst., 95: 625-627, 2003.
20. Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., and Fagin, J. A. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res., 63: 1454-1457, 2003.
21. Tannapfel, A., Sommerer, F., Benicke, M., Katalinic, A., Uhlmann, D., Witzigmann, H., Hauss, J., and Wittekind, C. Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut, 52: 706-712, 2003.
22. Singer, G., Oldt, R. 3rd, Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., and Shih le, M. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J. Natl. Cancer Inst., 95: 484-486, 2003.
23. Maeda, S., Yoshida, H., Ogura, K., Mitsuno, Y., Hirata, Y., Yamaji, Y., Akanuma, M., Shiratori, Y., and Omata, M. H. pylori activates NF-κB through a signaling pathway involving IκB kinases. NF-κB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology, 119: 97-108, 2000.
24. Ijichi, H., Ikenoue, T., Kato, N., Mitsuno, Y., Togo, G., Kato, J., Kanai, F., Shiratori, Y., and Omata, M. Systematic analysis of the TGF-β-Smad signaling pathway in gastrointestinal cancer cells. Biochem. Biophys. Res. Commun., 289: 350-357, 2001.
25. Kanai, F., Marignani, P. A., Sarbassova, D., Yagi, R., Hall, R. A., Donowitz, M., Hisaminato, A., Fujiwara, T., Ito, Y., Cantley, L. C., and Yaffe, M. B. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J., 19: 6778-6791, 2000.
26. Mason, C. S., Springer, C. J., Cooper, R. G., Superti-Furga, G., Marshall, C. J., and Marais, R. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J., 18: 2137-2148, 1999.
27. Tzivion, G., Luo, Z., and Avruch, J. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature (Lond.), 394: 88-92, 1998.
28. Grammatikakis, N., Lin, J. H., Grammatikakis, A., Tsichlis, P. N., and Cochran, B. H. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. Mol. Cell. Biol., 19: 1661-1672, 1999.
29. Dhillon, A. S., Meikle, S., Yazici, Z., Eulitz, M., and Kolch, W. Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J., 21: 64-71, 2002.
30. Pearson, G., Bumeister, R., Henry, D. O., Cobb, M. H., and White, M. A. Uncoupling Raf1 from MEK1/2 impairs only a subset of cellular responses to Raf activation. J. Biol. Chem., 275: 37303-37306, 2000.
31. Chuang, T. T., Iacovelli, L., Sallese, M., and De Blasi, A. G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci., 17: 416-421, 1996.
32. Pitcher, J. A., Freedman, N. J., and Lefkowitz, R. J. G protein-coupled receptors. Annu. Rev. Biochem., 67: 653-692, 1998.